CJC-1295 (DAC) – Long-Acting Growth Hormone Releasing Peptide

 What is CJC-1295 (Drug Affinity Complex)?

CJC-1295 (DAC) is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH) designed with Drug Affinity Complex (DAC) technology, allowing it to bind to albumin and extend its half-life significantly.

This modification enables sustained stimulation of growth hormone release, making it a highly studied compound in endocrinology, metabolic research, and anti-aging science.

CJC-1295 (DAC) is intended strictly for laboratory and scientific research use only, where permitted in regions including the United States 🇺🇸, United Kingdom 🇬🇧, Germany 🇩🇪, United Arab Emirates 🇦🇪, Australia 🇦🇺, Canada 🇨🇳, France 🇫🇷, Saudi Arabia 🇸🇦, and Switzerland 🇨🇭.

---

 Key Research Applications

Growth Hormone Secretion Studies

CJC-1295 (DAC) is widely researched for its ability to stimulate sustained growth hormone release through pituitary interaction.

 Anti-Aging & Longevity Research

Scientists study its role in age-related hormone decline, cellular regeneration, and biological aging pathways.

 Metabolic Function Research

CJC-1295 is used in studies exploring fat metabolism, lean mass regulation, and energy balance mechanisms.

---

 Why Researchers Choose CJC-1295 (DAC)

• Extended half-life due to Drug Affinity Complex (DAC) technology
• Long-acting growth hormone stimulation model
• High purity peptide for consistent lab results
• Strong relevance in endocrinology and metabolic studies
• Widely referenced in peptide and anti-aging research

---

 Global Scientific Interest

CJC-1295 (DAC) is actively studied in advanced research environments across:
United States, United Kingdom, Germany, France, Switzerland, Canada, Australia, China, United Arab Emirates, and Saudi Arabia.

Its popularity continues to grow in biotechnology, hormone research, and longevity science sectors.

---

 Mechanism Overview (Research Context)

 Albumin Binding Technology

The DAC component allows CJC-1295 to bind to albumin in circulation, extending its activity window and improving research stability.

Pituitary Stimulation Pathway

CJC-1295 interacts with growth hormone-releasing hormone receptors in the pituitary gland, influencing endogenous hormone secretion pathways.

---

Storage & Handling Guidelines

For research consistency, CJC-1295 (DAC) should be handled using standard peptide laboratory protocols, typically stored in a cool, dry, and controlled environment to maintain stability.

---

 Important Notice

This product is strictly intended for research and laboratory use only. It is not intended for human consumption, medical treatment, or diagnostic use